Geopolitics, US BIOSECURE: Pharma Looks To Redistribute CDMO Footprint

 
• By Anju Ghangurde

A redistribution of pharma outsourcing activities, both ex-China and also a wider shift in CDMO work from North America down the line may be in store. A senior McKinsey executive discusses with Scrip these trends in the CDMO sector amid geopolitical tensions, the spurt in customer queries at Indian firms and also facets of the deals scenario.

Anirudh Roy Popli, Partner, McKinsey & Company, Talks About Shifts In Pharma's CDMO Footprint

More from Business

More from Leadership